Phibro Animal Health Corp banner

Intrinsic Value

The intrinsic value of Phibro Animal Health Corp (PAHC) under the Base Case is 40.3 USD per share. Compared with the current market price of 35.44 USD, the stock appears Undervalued by 12% .

The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 4% a year over the next five years, less than a third of its five-year pace of 13%. If revenue grew at its five-year pace of 13%, the estimate would be about $65.

Do our valuations actually work? See backtest results .

PAHC Intrinsic Value
$40.3
Undervaluation 12%
Intrinsic Value
Price $35.44
Alert me when PAHC is below its intrinsic value
Today $32.24 · 9.0% below the current price

PAHC is valued in line with its history. A discount of this size has been typical over the past 5 years.

Alternatives to PAHC

Fundamental Analysis

What Phibro Animal Health Does

Pharmaceuticals Health Care

Phibro Animal Health makes products that help keep farm animals healthy and productive. It sells animal health medicines, medicated feed additives, nutritional supplements, and vaccines used mainly for poultry, swine, cattle, and aquaculture, with a smaller business serving pets. The company also produces specialty ingredients such as mineral nutrition products that go into animal feed.

Headquarters
United States of America US
Employees
2 475
IPO date
Apr 11, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Phibro Animal Health Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

PAHC Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PAHC stock?

The intrinsic value for Phibro Animal Health Corp (PAHC) under the Base Case is 40.3 USD.

Is PAHC stock undervalued or overvalued?

Compared with the current market price of 35.44 USD, the stock appears Undervalued by 12% .

Back to Top